[HTML][HTML] Biomarkers for osteoarthritis: Current status and future prospects

A Mobasheri, CS Thudium, AC Bay-Jensen… - Best Practice & …, 2023 - Elsevier
Osteoarthritis (OA) is the most common form of arthritis globally and a major cause of pain,
physical disability, and loss of economic productivity, with currently no causal treatment …

Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions

MMI Abdalla - Therapeutic Advances in Endocrinology and …, 2024 - journals.sagepub.com
Adiponectin, an adipose-derived hormone, plays a pivotal role in glucose regulation and
lipid metabolism, with a decrease in circulating adiponectin levels being linked to insulin …

The Application of Evidence-Based Medicine in Individualized Medicine

P Van de Vliet, T Sprenger, LFC Kampers… - Biomedicines, 2023 - mdpi.com
The fundamental aim of healthcare is to improve overall health of the population by
providing state-of-the-art healthcare for individuals at an affordable cost. The foundation for …

[HTML][HTML] Peri‐implant gas accumulation in response to magnesium‐based musculoskeletal biomaterials: Reframing current evidence for preclinical research and …

Y Sun, H Helmholz, R Willumeit-Römer - Journal of Magnesium and Alloys, 2024 - Elsevier
Historically, the rapid degradation and massive gas release from magnesium (Mg) implants
resulted in severe emphysema and mechanical failure. With the advent of new alloys and …

[HTML][HTML] Optimizing mesenchymal stem cell extracellular vesicles for chronic wound healing: Bioengineering, standardization, and safety

Y Shimizu, EH Ntege, Y Inoue, N Matsuura… - Regenerative …, 2024 - Elsevier
Chronic wounds represent a significant global burden, afflicting millions with debilitating
complications. Despite standard care, impaired healing persists due to factors like persistent …

Successfully navigating the valley of death: the importance of accelerators to support academic drug discovery and development

M Everts, M Drew - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction The drug discovery and development 'valley of death'remains a challenge for
promising new therapies originating from academic research laboratories. Drug discovery …

An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk

S Cherradi, N Taulet, HT Duong - In vitro models, 2023 - Springer
One major drawback of preclinical models to test drug-induced liver injury (DILI) is their
inability to predict the interindividual difference of DILI effect in a population. Consequently …

精准医疗临床研究的关键挑战与优化建议

杜静婷, 冷烨, 祁婉婷, 韩洞明, 王丽丽, 黄慧瑶… - 中国医药导刊, 2024 - zgyydk.cn
近年来, 随着现代生物技术的成熟, 在国际社会共同推动下, 致力于为患者提供个性化医疗服务的
精准医疗及其相关临床研究取得了显著进展. 为促进精准医疗研究及其发展环境的优化 …

Nanotheranostics in Personalized Veterinary Medicine

M Ghosh, A Chowdhury, R Kumar - Nanotechnology Theranostics in …, 2024 - Springer
Nanotheranostics, a rapidly advancing field at the intersection of nanotechnology and
theranostics, holds great promise for revolutionizing personalized veterinary medicine. The …

Supporting evidence in phase 2 cancer trial protocols: A content analysis

S Bicer - 2024 - escholarship.mcgill.ca
Background: Phase 2 trials bridge a clinical strategy that shows promise in preclinical
studies to late phase trials that confirm its value. However, high failure rates of these trials …